As policymakers in Washington make vital funding and program decisions on global health, we need to showcase the work of global HIV/AIDS and TB scientists and physicians who are on the front-lines of preventing and treating these twin global epidemics. We’re looking for compelling stories about what’s happening in the research labs, the clinical […]
Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, has a very informative op-ed in today’s Washington Post outlining “three bold new approaches” to curtailing the HIV/AIDS pandemic. “Vaccines have historically been mankind’s best weapon against the worst infectious diseases,” he writes. “But HIV’s unique and formidable nature has presented challenges to […]
The National Institutes of Health is seeking grant applications for its Microbicide Innovation Program. The agency is looking for projects that will advance the development of new microbicides or shed new light on the characterization of microbicides for use against HIV or STIs linked to HIV, among other scientific pursuits. Here’s the link for […]
The Fogarty International Center announced $11.75 million in grants over the next five years to fight HIV/AIDS and tuberculosis in Haiti, Uganda and China and to establish a new program in Tanzania. The grants will help train researchers from those countries on HIV and TB prevention, among other things. “Research has identified many […]
Your know-how is needed to help the Global Drug Facility review grants for free anti-TB drugs. The GDF is looking for candidates to serve on its Technical Review Committee; nominees should have experience in clinical TB, TB diagnostics, drug management, international development, or other relevant fields. Here’s more info, including how to apply […]
HIV
The following is a guest post by Maureen Luba Milambe, African Regional Advocacy Advisor, AVAC On Tuesday (June 8), the UN General Assembly voted overwhelmingly to […]
Tuberculosis
The publication of trial data showing a four-month treatment regimen for tuberculosis that is not resistant to first-line medicines as effective as the currently widely prescribed […]
Research & Development
By Mitchell Warren, executive director, AVAC In February 2020, just as the COVID pandemic began its rapid global spread, a major HIV vaccine trial called HVTN […]
Policy
By Karen Carvajal, M.D. Over the course of human history we have come a long way in our fight against the threat of infectious diseases and, […]